Ignite Creation Date:
2024-10-26 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06516016
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-06-06
Brief Title:
Multimodal Markers of Neurodegenerative Disorders at Presymptomatic Stages
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Multimodal Markers of Neurodegenerative Disorders at Presymptomatic Stages
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
NEUROPREMS
Brief Summary:
NeuroPrems is a prospective monocentric longitudinal not relating to a medicinal product for human use non-randomized non-controlled research The study mainly aims to identify longitudinal changes and events in multimodal markers of neurodegeneration and neuroinflammation during the presymptomatic phases of neurodegenerative diseases
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None